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bjectives Our aim was to develop a “standby intracardiac echocardiography” approach to patent
oramen ovale (PFO) closures where intracardiac echocardiography (ICE) is only utilized where there
re adverse features.
ackground Percutaneous closure of PFO is usually aided by transesophageal echocardiography or
CE. This may be unnecessary where anatomical features are straightforward.
ethods Patients were excluded from standby ICE if they had adverse anatomical features on their
iagnostic transoesophageal echocardiogram, a device other than Amplatzer (AGA Medical, Plym-
uth, Minnesota), STARﬂex (NMT Medical, Boston, Massachusetts), or BioSTAR (NMT Medical) were to
e used, or they were in a clinical trial demanding ICE/transesophageal echocardiography. Procedur-
lly, defect diameter 15 mm on balloon sizing and tunnel length 12 mm warranted ICE
uidance.
esults Between April 2006 and October 2007, 124 patients underwent PFO closure. Fifty-four were
xcluded from standby ICE due to trial protocols (n  22), hybrid atrial septal defect/PFO (n  6),
dditional defect (n  4), exuberant aneurysm (n  3), or other device (n  19, all HELEX, Gore
edical, Flagstaff, Arizona). The remaining 70 patients were age 38.1  6.4 years, 49% men. Primary
ndication for PFO closure was stroke (n  46, 65%), transient ischemic attack (n  22, 31%), or de-
ompression illness (n  2, 3%). Sixty-four (91%) underwent contrast ﬂuoroscopic PFO closure alone.
ix patients (9%) converted to ICE-controlled closure: PFO sized to 15 mm (n  2); difﬁculties
rossing PFO (n  2), or long tunnel requiring transseptal puncture (n  2). All 70 patients had pro-
edural success without signiﬁcant complications. Procedure duration and cost favored standby ICE.
onclusions PFO closure can, in the majority of cases, be performed safely using contrast media
nd ﬂuoroscopy alone. Standby ICE facilitates closure in the remaining patients during the index
rocedure. (J Am Coll Cardiol Intv 2008;1:387–91) © 2008 by the American College of Cardiology
oundation
rom the *Sussex Cardiac Centre, Brighton and Sussex University Hospital NHS Trust, Brighton; and the †Department of
ardiology, King’s College Hospital NHS Foundation Trust, London, United Kingdom.anuscript received March 10, 2008; revised manuscript received May 14, 2008, accepted May 20, 2008.
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388ercutaneous closure of patent foramen ovale (PFO) is an
stablished treatment for cryptogenic stroke, orthodeoxia-
latypnea syndrome, and decompression illness (1–3), and
n investigative treatment for other indications (4,5). Al-
hough randomized data are lacking, except in the setting of
igraine headache (6,7), PFO closure is an increasingly
ommon interventional procedure.
See page 392
The procedure has traditionally been done under general
nesthesia with transesophageal echocardiographic (TOE)
ontrol (8). However, increasing operator experience, cou-
led with sophistication of devices and delivery equipment,
ave led to streamlining of the procedure, with the result
hat online echocardiographic assessment per procedure
ay not be necessary in all cases. Intracardiac echocardiog-
aphy (ICE) allows PFO closure to be undertaken without
eneral anesthesia, with associated benefits for patients (9).
eneral anesthesia has several complications, which, al-
hough rare, can be very serious such as aspiration pneumo-
itis. ICE, however, is expensive, and requires additional
equipment and personnel in the
cardiac catheterization lab, po-
tentially prolonging the proce-
dure and limiting operational
flexibility. ICE requires addi-
tional femoral venous cannula-
tion, which exposes the patient
to increased risk of groin com-
plications such as arteriovenous
fistula formation.
As a result, we have developed the option of “standby”
CE, such that PFO closure can be undertaken under
ontrast injections and fluoroscopy alone, with use of ICE
nly if there are unfavorable anatomical features, or techni-
al difficulties with PFO crossing or with device positioning
r deployment. We present our experience of this practice.
ethods
atients referred to either of 2 cardiothoracic centers for
FO closure between April 2006 and October 2007 were
outinely considered for contrast-guided fluoroscopic clo-
ure and standby ICE. All patients were referred by neu-
ologists to be considered for PFO closure in the context of
ryptogenic stroke, decompression illness, or migraine
within clinical trials). The study protocol was approved by
he local ethics committee, and patients gave written in-
ormed consent.
All patients had formal TOE assessment of the interatrial
eptum before planned closure, to delineate the anatomical
bbreviations
nd Acronyms
SD  atrial septal defect
CE  intracardiac
chocardiography
FO  patent foramen ovale
OE  transesophageal
chocardiographyeatures of the septum and/or as the diagnostic modality. re-procedure exclusion criteria for fluoroscopic closure
lone were:
Clinical trial requiring ICE or TOE as part of the
protocol
Hybrid atrial septal defect (ASD)/PFO defect (i.e.,
resting left to right shunt as well as right to left)
Additional interatrial septal defects
Exuberant aneurysm
Device other than Amplatzer, STARflex, or BioSTAR
“Exuberant aneurysm” is a subjective assessment. This
erm describes an extreme aneurysm with considerable
edundant tissue with different folds of tissue moving in
ifferent directions. For the implantation procedure, an
1-F sheath was introduced into the right femoral vein,
ith the option of placement of a second 11-F sheath for
he ICE catheter (from ipsilateral or contralateral femoral
ein) so that the procedure could be completed at the same
itting if ICE proved necessary. If difficulties were encoun-
ered with crossing the PFO, ICE was utilized on this
tandby basis to facilitate crossing. Once the defect had been
rossed, balloon sizing of the defect was made in all cases.
he use of the balloon is beneficial because it allows the
ssessment of the “size” of the PFO, tunnel length, and
recise fluoroscopic delineation of the location of the PFO.
hese benefits were felt to outweigh its potential compli-
ations such as tearing the intra-atrial septum or extending
he PFO. Fluoroscopy-only closure was not attempted in
ases where the balloon size of the PFO was 15 mm, nor
here the tunnel length was 12 mm, and in these cases
CE was utilized.
Amplatzer, STARflex, or BioSTAR devices were used in
ll cases. Use of the appropriate delivery sheath allowed
ontrast assessment of the positioning of the device after
eployment of the left atrial disc (Fig. 1). The right atrial
isc could then be placed, and final contrast assessment of
he anatomical placement made (Fig. 2).
tatistical analysis. Continuous variables were expressed as
eans and standard deviations and were compared by a
-way analysis of variance with post hoc tests. Significance
as assumed with a p value of 0.05.
esults
uring the period under consideration (April 2006 to
ctober 2007), 124 patients underwent PFO closure at the
centers. Fifty-four patients were excluded from standby
CE closure on the grounds of trial protocols (n  22),
ybrid ASD/PFO (n  6), additional defect (n  4),
xuberant aneurysm (n  3), or other device (n  19, all
ELEX). Seventy patients were therefore considered for
tandby ICE PFO closure. These 70 patients were age 38.1
6.4 years, 49% men. Primary indication for PFO closure
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389as stroke (n  46, 65%), transient ischemic attack (n  22,
1%), and decompression illness (n  2, 3%).
Of the 70 patients listed for standby ICE PFO closure,
4 (91%) underwent contrast fluoroscopic PFO closure
lone. Six patients converted to ICE-controlled closure on
he grounds of PFO sized to 15 mm (n  2); difficulties
rossing PFO (n  2), long tunnel requiring transseptal
uncture (n  2). Patients were divided between Amplatzer
n  43), STARflex (n  21), and BioSTAR (n  6)
evices.
Of the 64 patients who underwent contrast-fluoroscopic-
nly implantation, all 64 had procedural success, with
ppropriate deployment of the device confirmed both fluo-
oscopically and on transthoracic echocardiography the next
ay before discharge. There were no device embolizations or
ther major complications. Contrast fluoroscopy delineated
orrect placement of the device on the interatrial septum in
ll cases. The other 6 cases that went on to ICE-guided
losure also had successful procedures, again with confirma-
ion of good device placement on transthoracic echocardi-
graphy the next day and no major complications.
Procedure duration, fluoroscopy time, and diamentor are
hown for the 124 cases undertaken during this time (Table
). For the 70 cases in which fluoroscopic closure was
ttempted, procedure duration compares favorably with the
Figure 1. Contrast Assessment of the Positioning of the Device After
Deployment of the LA Disc
LA  left atrium/atrial; RA  right atrium.rocedural duration for patients undergoing planned ICE-uided closure, or planned TOE-guided closure (under
eneral anesthetic) during the same period.
Cost was estimated for each of the 3 modalities. Crude
nalysis was made on the basis of €5,000 per device, €2,500
or general anesthetic/TOE, €2,500 for ICE, €1,000 for
isposables, €1,000 for overnight stay, and €500 for trans-
horacic echocardiography. Results are also shown in
able 1.
iscussion
FO closure is a procedure with a “zero tolerance” of
omplications. Recurrence rates for cryptogenic stroke are
Figure 2. The Final Contrast Assessment of the Anatomical Placement of
the RA Disc
Abbreviations as in Figure 1.
Table 1. Procedural Characteristics and Cost
A: Standby ICE
(n  70)
B: Planned ICE
(n  31)
C: Planned GA/TOE
(n  23)
Duration (min)
(mean  SD)
42.1 7.2* 49.4 5.4* 68.4 12.9
Fluoroscopy time (min)
(mean  SD)
6.4 4.8 5.6 3.7 5.7 4.9
Diamentor (cGy/m2)
(mean  SD)
924 231 811 322 723 419
Cost (€) €7,500 €10,000† €10,000†
*p 0.05 versus C; †p 0.05 versus A. Procedure duration, fluoroscopy time, and diamentor
are shown for the 124 cases undertaken during this time.
GA general anesthesia; ICE intracardiac echocardiography; SD standard deviation;TOE transesophageal echocardiogram.
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390ow (10), and therefore PFO closure must be performed to
n exacting safety standard. As a result, there is a conflict
etween streamlining and simplification of the procedure on
he one hand, and maintenance of absolute clinical safety on
he other. While cost is always an issue, reduction of cost
ust not be at the expense of procedural safety. Further
tudies will need to be undertaken to see whether there are
isks associated with PFO closure done using contrast media
nd fluoroscopy alone, which are not appreciated in this
eport. Current estimations of cost, however, do suggest a
ignificant potential saving with use of standby ICE rather
han planned ICE or planned TOE.
In most cases, PFO closure is a straightforward proce-
ure, assuming that a comprehensive assessment of the
natomy of the interatrial septum has been made before-
and with a TOE such that more complex interatrial
natomies are not attempted fluoroscopically alone.
luoroscopic-guided PFO closure is not suitable for all
ases. However, contrast delineation of the interatrial sep-
um is surprisingly good, particularly when using the left
nterior oblique cranial projection, which profiles the sep-
um in the majority of cases. With the Amplatzer, STAR-
ex, or BioSTAR systems, it is possible to inject contrast
nce the left atrial disc is exposed to ensure that placement
f the disc is correct on the left atrial side of the septum.
are must be taken to ensure that the delivery sheath is fully
urged of any small air bubbles, otherwise transient inferior
T-segment elevation will result as the bubbles pass pref-
rentially into the right coronary artery circulation with the
atient supine (11). Once the right atrial disc is exposed, a
urther contrast fluoroscopic image can be acquired, to
nsure that the device is correctly sandwiching the defect,
ith the appropriate “Pacman sign” (12).
If balloon sizing demonstrates a PFO 15 mm in
iameter, we believe that it is not appropriate to continue to
losure without ICE control, in view of the risk that the
efect may be an unsuspected ASD, or that it has particu-
arly flimsy margins. Continuing with fluoroscopic closure
nder these circumstances might risk device embolization.
Cases where standby ICE was used include 2 cases where
 particularly long tunnel was demonstrated and a decision
as therefore made to close the PFO using a transseptal
uncture (13) (Fig. 3). In these cases, imaging is essential to
nsure that the transseptal puncture is made directly below
he septum secundum to ensure that the septum secundum
s sandwiched to the septum primum by the closure device;
therwise a higher rate of residual shunting may be observed
14).
Fluoroscopic-only closure has been advocated by Dr.
eier’s group for several years (15). Procedural results have
een excellent, as have follow-up closure rates. It is notable
owever that there have been some device embolizations in
his group’s series (5 of 525 patients), and it may be possible
o reduce this risk with a more selective fluoroscopy-onlypproach. Using standby ICE at least allows the operator to
dd echocardiographic imaging if there are unexpected
ifficulties, without resorting to case cancellation and re-
ooking.
The authors of this paper believe that PFO closure can, in
he majority of cases, be performed safely and with the
ppropriate zero tolerance of complications using contrast
edia and fluoroscopy alone. Standby ICE facilitates clo-
ure in the remaining cases during the index procedure. It is
ow the authors’ practice to do PFO closure without
chocardiographic guidance in the substantial majority of
ases.
eprint requests and correspondence: Dr. David Hildick-Smith,
ussex Cardiac Centre, Brighton and Sussex University Hospitals
HS Trust, Brighton, United Kingdom, BN2 5BE. E-mail:
avid.Hildick-Smith@BSUH.nhs.uk.
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